Product Description
Maltodextrins (MDs) are a class of carbohydrates (CHOs) extracted from a range of botanical sources.
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Chile | France | Greece | Malaysia | Spain | Taiwan | United Arab Emirates | United Kingdom | Uruguay
Approved Indications: None
Known Adverse Events: None
Company: Nestle
Company Location: VEVEY V8
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Australia, Sweden
Active Clinical Trial Count: 3
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Other
Phase 2: Obesity|Overweight
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| POEM | P2 |
Not yet recruiting |
Overweight|Obesity |
2025-07-29 |
50% |
2025-05-29 |
Primary Endpoints|Treatments |
| MAOGIT | P3 |
Completed |
Other |
2025-07-23 |
8% |
2025-08-27 |
|
| EP-005 | P2 |
Not yet recruiting |
Obesity |
2025-08-31 |
50% |
2025-05-02 |
Treatments |